ResMed | RMD - Des Atouts

Prix De L'Action
201.88
Variation Quotidienne
-0.58 -0.29%
Mensuellement
-10.16%
Annuel
-19.79%
Q2 Prévisions
197.82




Des Atouts Changement Date
Ansell USD 3.33B 3.2M 2025-12
Artivion USD 883.16M 1.64M 2026-03
AtriCure USD 643.99M 10.19M 2026-03
Baxter International USD 19.85B 209M 2026-03
Cochlear AUD 2.79B 31.3M 2025-12
Cooper Companies USD 12.42B 29.4M 2025-12
CSL USD 37.9B 1.5B 2025-12
Dexcom USD 6.63B 293.4M 2026-03
Edwards Lifesciences USD 13.32B 376M 2026-03
Fisher Paykel Healthcare NZD 2.63B 80.5M 2025-12
Globus Medical USD 5.44B 136.79M 2026-03
Haemonetics USD 2.49B 48.73M 2025-12
Idexx Laboratories USD 3.39B 34.74M 2026-03
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 2.99B 203.2M 2026-03
Integra LifeSciences USD 3.58B 24.28M 2026-03
Intuitive Surgical USD 20.11B 347.7M 2026-03
Masimo USD 1.64B 56.2M 2026-03
Medtronic USD 91.48B 139M 2025-12
Philips EUR 27.27B 322M 2026-03
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.78B 280.91M 2026-03
Sigma Healthcare AUD 8.29B 6.91B 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Steris USD 10.74B 145.8M 2026-03
Teleflex USD 6.78B 164.24M 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03